Screener
Nuvation Bio NUVB Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product revenue, net | $23,192 | $1,238 | $41,702 | $1,238 |
| Collaboration and license agreements revenue | 8,495 | 3,595 | 73,213 | 6,679 |
| Total revenue | 31,687 | 4,833 | 114,915 | 7,917 |
| Costs and expenses: | ||||
| Cost of sales | 911 | 172 | 1,286 | 172 |
| Cost of collaboration and license agreements revenue | 8,560 | 2,404 | 14,176 | 4,498 |
| Research and development | 30,661 | 27,362 | 65,708 | 51,963 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's total revenue?
- Nuvation Bio (NUVB) reported total revenue of $31.69M in Q2 2026.
- How has Nuvation Bio's total revenue changed year-over-year?
- Nuvation Bio's total revenue increased by 555.6% year-over-year, from $4.83M to $31.69M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Nuvation Bio's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude